Exposure to pollen can raise your risk of developing COVID-19, and it isn’t just a problem for people with allergies, new research released March 9 shows. Plant physiologist Lewis Ziska, a co-author of the new peer-reviewed study and other recent…
Read More
Spacing COVID-19 vaccine doses has benefits, but longer-term outcomes depend on robust immunity
Delaying second doses of COVID-19 vaccines should reduce case numbers in the near term. But the longer-term case burden and the potential for evolution of viral “escape” from immunity will depend on the robustness of immune responses generated by natural…
Read More
Study looks at effect of COVID-19 policies on vehicle crashes, traffic volume in Ohio
To minimize transmission of COVID-19, in spring 2020, most U.S. states passed policies promoting social distancing through stay-at-home orders prohibiting non-essential travel. Vehicle-miles traveled in the U.S. decreased by 41% in April 2020 compared to 2019. A new study led…
Read More
Cheers and Hope as Doctor Gets Nigeria’s First COVID-19 Vaccine
ABUJA (Reuters) – A doctor who has spent the past year treating COVID-19 patients on Friday became the first person in Nigeria to be vaccinated against the disease, kicking off a mammoth campaign that aims to inoculate 80 million people…
Read More
Americans vaccinated against COVID-19 still wait for advice
More than 27 million Americans fully vaccinated against the coronavirus will have to keep waiting for guidance from federal health officials for what they should and shouldn’t do. The Biden administration said Friday it’s focused on getting the guidance right…
Read More
WHO to Scrap Interim Report on Probe of COVID-19 Origins: WSJ
(Reuters) – A World Health Organization team investigating the origins of COVID-19 is planning to scrap an interim report on its recent mission to China amid mounting tensions between Beijing and Washington over the investigation and an appeal from one…
Read More
Easy-to-deliver mRNA treatment shows promise for stopping flu and COVID-19 viruses
With a relatively minor genetic change, a new treatment developed by researchers at the Georgia Institute of Technology and Emory University appears to stop replication of both flu viruses and the virus that causes COVID-19. Best of all, the treatment…
Read More
US NIH Halts Trial Testing COVID-19 Blood Plasma
(Reuters) — The U.S. National Institutes of Health (NIH) said on Tuesday it had halted a trial testing convalescent blood plasma in treatment of patients with mild to moderate COVID-19 symptoms. The NIH said an independent data monitoring board found…
Read More
Contagious Brazil COVID Variant Evades Immunity, Scientists Warn
LONDON (Reuters) – A highly transmissible COVID-19 variant that emerged in Brazil and has now been found in at least 20 countries can re-infect people who previously recovered from the disease, scientists said on Tuesday. In a study of the…
Read More
UK to Prioritize Next Stage of COVID Vaccine by Age, Not Job
LONDON (Reuters) – Police and teachers will not jump to the head of the queue in the second phase of Britain’s COVID-19 vaccination rollout, with people instead prioritised by age, officials advising the government said on Friday, describing this as…
Read More